Introduction: Leishmaniasis broadly manifests as visceral leishmaniasis (VL), cutaneous
leishmaniasis (CL) and mucocutaneous leishmaniasis. The treatment of leishmaniasis is …

Limited therapeutic options in visceral leishmaniasis (VL) make the treatment of this
neglected disease very challenging. In addition to this, long treatment duration and toxic …

It is important to realize that leishmaniasis guidelines cannot always account for individual
variation among patients. They are not intended to supplant physician judgment with respect …

Leishmaniasis remains a neglected tropical disease, with a need for additional clinical trials
with better design and reported endpoints to lead evidence-based treatment …

INTRODUCTION Visceral leishmaniasis (VL) is a neglected disease, with territorial
expansion and regional differences in Brazil that require explanation. This study aimed to …

Co-infection among leishmaniasis and other infectious diseases is common among natural
populations especially in the endemic areas of the disease. It depends on the environmental …

Background Over the last three decades, the epidemiological profile of visceral
leishmaniasis (VL) has changed with epidemics occurring in large urban centers of Brazil …

This study aimed to analyse the spatial distribution of human (2007-2013) and canine
(2013) visceral leishmaniasis (VL) in the city of Araçuaí, Minas Gerais, Brazil, and identify …

ABSTRACT Introduction: Visceral Leishmaniasis is the most severe form of disease caused
by the Leishmania donovani complex, with significant morbidity and mortality in developing …

Human visceral leishmaniasis (HVL) cases are important public health problems due to their
zoonotic aspect, with high rates of morbidity and mortality in Brazil. The aim of this this study …